You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

VCTE

Showing 1 - 25 of 54
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Liver Steatosis Trial (Transparietal ultrasound (US)-based shear wave elastography (SWE), Vibration-controlled transient

Not yet recruiting
  • Liver Steatosis
  • Transparietal ultrasound (US)-based shear wave elastography (SWE)
  • +2 more
  • (no location specified)
Oct 21, 2023

Spleen; Fibrosis Trial in Rotterdam, Cluj-Napoca, Madrid (FibroScan examination (S), FibroScan examination (M), FibroScan

Recruiting
  • Spleen; Fibrosis
  • FibroScan examination (S)
  • +3 more
  • Rotterdam, Netherlands
  • +3 more
Aug 5, 2022

Liver Fibrosis Trial in France (Research FibroScan)

Completed
  • Liver Fibrosis
  • Research FibroScan
  • Amiens, France
  • +5 more
Oct 12, 2021

Disease of Liver and Bile Duct Trial in Buffalo (vibration controlled transient elastography (VCTE))

Recruiting
  • Disease of Liver and Bile Duct
  • vibration controlled transient elastography (VCTE)
  • Buffalo, New York
    Conventus Medical Office Building
Apr 15, 2022

Liver and Intrahepatic Bile Duct Carcinoma Trial in Houston (Clinical Evaluation, Laboratory Biomarker Analysis, Liver

Recruiting
  • Liver and Intrahepatic Bile Duct Carcinoma
  • Clinical Evaluation
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 7, 2022

The Nijmegen-Leiden-Amsterdam 2-tiered Care Path Study

Recruiting
  • Non-Alcoholic Fatty Liver Disease
  • FIB4-score
  • +2 more
  • Nijmegen, Gelderland, Netherlands
  • +2 more
Feb 1, 2023

Hepatocellular Carcinoma, Nonalcoholic Steatohepatitis Trial in Tarzana, New York, Durham (Lisinopril, Questionnaire

Recruiting
  • Hepatocellular Carcinoma
  • Nonalcoholic Steatohepatitis
  • Biospecimen Collection
  • +6 more
  • Los Angeles, California
  • +3 more
Dec 8, 2022

Portal Hypertension in Compensated Advanced Chronic Liver

Recruiting
  • Advanced Chronic Liver Disease, NASH
  • VCTE with splenic stiffness measurement
  • Indianapolis, Indiana
    Indiana University School of Medicine
Jan 13, 2021

Fatty Liver, NAFLD Trial in Kansas City (ELF Test)

Recruiting
  • Fatty Liver
  • NAFLD
  • ELF Test
  • Kansas City, Kansas
    University of Kansas Medical Center
May 6, 2022

NASH With Fibrosis Trial in Beijing

Not yet recruiting
  • NASH With Fibrosis
    • Beijing, Beijing, China
      Beijing Tsinghua Changgung Hospital
    Nov 3, 2023

    NMR-based Metabolic Profiling Identifies High Risk of MAFLD

    Not yet recruiting
    • Metabolic Dysfunction-associated Fatty Liver Disease
    • Metabolic Disease
    • NMR-based metabolic profiling
    • Wuhan, Hubei, China
      Tongji hospital, Tongji Medical College, Huazhong University of
    Feb 8, 2023

    Nonalcoholic Fatty Liver Disease in HIV Database

    Recruiting
    • NAFLD
    • +2 more
      • Birmingham, Alabama
      • +7 more
      Jan 11, 2023

      NON-ALCOHOLIC STEATOHEPATITIS Trial in United States (DA-1241, Sitagliptin, DA-1241 Placebo)

      Recruiting
      • NON-ALCOHOLIC STEATOHEPATITIS
      • Rialto, California
      • +5 more
      Sep 19, 2023

      NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes

      Active, not recruiting
      • Nonalcoholic Fatty Liver
      • +4 more
      • Transient Elastography
      • Boston, Massachusetts
        Joslin Diabetes Center
      Sep 16, 2022

      Hepatitis D, Chronic Trial in Worldwide (JNJ-73763989, Placebo, Entecavir (ETV) monohydrate)

      Active, not recruiting
      • Hepatitis D, Chronic
      • Redwood City, California
      • +68 more
      Jan 17, 2023

      Fatty Liver, Nonalcoholic Trial (SGLT2 inhibitor)

      Not yet recruiting
      • Fatty Liver, Nonalcoholic
      • SGLT2 inhibitor
      • (no location specified)
      Oct 31, 2023

      Liver Cirrhosis Network Cohort Study

      Recruiting
      • Cirrhosis
      • +10 more
        • La Jolla, California
        • +13 more
        Feb 21, 2023

        Intestinal Failure Associated Liver Disease Trial (NST-6179 Part A, NST-6179 Part B, Matched Placebo)

        Not yet recruiting
        • Intestinal Failure Associated Liver Disease
        • NST-6179 Part A
        • +2 more
        • (no location specified)
        Jun 23, 2023

        Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, Type 2 Diabetes Trial in Al Ain (GIP/GLP-1a)

        Not yet recruiting
        • Non-Alcoholic Fatty Liver Disease
        • +3 more
        • Al Ain, Abu Dhabi, United Arab Emirates
          Internal Medicine, College of Medicine and Health Sciences
        Mar 1, 2023

        Cirrhosis, Cirrhosis, Liver, Cirrhosis Early Trial in United States (Rosuvastatin)

        Not yet recruiting
        • Cirrhosis
        • +10 more
        • La Jolla, California
        • +12 more
        Apr 14, 2023

        Nonalcoholic Steatohepatitis (NASH) Trial in Miami Lakes, Tulsa, Waco (HTD1801, Placebo)

        Recruiting
        • Nonalcoholic Steatohepatitis (NASH)
        • Miami Lakes, Florida
        • +2 more
        Jan 13, 2023

        Liver Diseases Trial in Clichy, Lyon, Nancy (Research FibroScan)

        Recruiting
        • Liver Diseases
        • Research FibroScan
        • Clichy, France
        • +2 more
        Nov 15, 2022

        Alpha1-Antitrypsin Deficiency Trial (Fazirsiran Injection, Placebo)

        Not yet recruiting
        • Alpha1-Antitrypsin Deficiency
        • Fazirsiran Injection
        • Placebo
        • (no location specified)
        Feb 2, 2023

        Hepatic Steatosis in Persons Living With HIV

        Recruiting
        • NAFLD
        • +2 more
          • Tuscaloosa, Alabama
          • +7 more
          Oct 4, 2022

          Primary Biliary Cholangitis (PBC) Trial (Elafibranor, Matched 80 mg )

          Not yet recruiting
          • Primary Biliary Cholangitis (PBC)
          • (no location specified)
          Aug 29, 2023